ArticleForum on immunopathological diseases and therapeutics2012

Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.

Khosrow KashfiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.